Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas. (Q40382332)
scientific article published on August 2005
Language:
(P31) (Q13442814)
(P50) (Q61820649)
(Q57003363)
(P304) 5878-5885
(P407) (Q1860)
(P433) 16
(P478) 11
(P577) Monday, August 1, 2005
(P921) (Q356033)
(P1433) (Q332253)
(P1476) "Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas" (language: en)
(P2093) Miguel Taron
Yukito Ichinose
Bartomeu Massuti
Jose Luis Mate
Christian Manegold
Mayumi Ono
Cristina Queralt
Thierry Jahan
Jose Javier Sanchez
Maria Sanchez-Ronco
Victor Hsue
David Jablons
Jose Miguel Sanchez
Teresa Moran
Rafael Rosell
other details
description scientific article published on August 2005

External Links